SEPSIS DIAGNOSTICS MARKET ANALYSIS
On April 13, 2023, AlgoDx, a company that provides artificial intelligence and machine learning evidence-based algorithms, announced that the US Food and Drug Administration has accepted for review the company’s De Novo application for NAVOY Sepsis, a clinical decision support software intended to assist healthcare providers at intensive care units (ICU) with predicting sepsis in adult ICU patients.
On June 13, 2023, DiaSorin, a biotechnology company, secured CE marking for an immunodiagnostic assay to aid diagnosis of severe conditions including sepsis, septic shock, kidney diseases, and lower respiratory and urinary tract infections, and the firm is launching the assay in Europe.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 